Europe is taking bold steps in transforming its biotech industry, from strengthening biotech ecosystems, simplifying regulatory framework, and accelerating trial authorizations, to creating better funding opportunities and supporting market uptake and expansion. This panel will bring together public and private funders, industry leaders, clinical trials networks, and entrepreneurs to explore how Europe’s evolving ecosystem is reshaping opportunities for biotech innovation. Speakers will compare experiences, highlight best practices, and discuss how new EU-level actions are supporting growth of biotech innovations. Attendees will gain a clear view of the new opportunities, incentives, and support mechanisms emerging across Europe — and how they can position their organizations to thrive in a more competitive and innovation-friendly European biotech environment.